Two Sigma Investments’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-47,617
Closed -$60K 3305
2022
Q4
$60K Buy
47,617
+4,597
+11% +$10.5K ﹤0.01% 2571
2022
Q3
$185K Buy
43,020
+42,462
+7,610% +$210K ﹤0.01% 2129
2022
Q2
$3K Sell
558
-14,706
-96% -$139K ﹤0.01% 2442
2022
Q1
$183K Sell
15,264
-560
-4% -$7.65K ﹤0.01% 2351
2021
Q4
$310K Buy
+15,824
New +$354K ﹤0.01% 3629
2021
Q3
Sell
-40,659
Closed -$895K 4875
2021
Q2
$895K Buy
40,659
+13,694
+51% +$336K ﹤0.01% 2580
2021
Q1
$631K Buy
+26,965
New +$829K ﹤0.01% 2705
2020
Q4
Sell
-5,621
Closed -$92K 3886
2020
Q3
$92K Buy
+5,621
New +$68.2K ﹤0.01% 2948

Other funds holding NMTR

Two Sigma Investments's NMTR Position: Q1 2023 in Review

Two Sigma Investments sold out of 9 Meters Biopharma (NMTR) in Q1 2023, closing a stake of 47,617 shares — an estimated $60K sold.

Two Sigma Investments first reported a position in NMTR in Q3 2020 and held it in 8 quarters. The position peaked at $895K in Q2 2021. 39 funds tracked by Wall St. Rank hold NMTR as of Q1 2023.

  • Two Sigma Investments reported no remaining 9 Meters Biopharma position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Investments sold 47,617 9 Meters Biopharma shares in Q1 2023, an estimated $60K.
  • Two Sigma Investments first reported a position in 9 Meters Biopharma in Q3 2020 and held it in 8 quarters.
  • Two Sigma Investments's 9 Meters Biopharma position peaked at $895K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.